SCK CEN

🏁 Belgian experts are ready to continue tackling the challenges of radioactive waste management at the European level 🏁 🔎 EURAD, the European Joint programme on radioactive waste management funded by #EURATOM, organized the kick-off meeting of the second leg of the project in Ghent this week. In EURAD-2, the focus is put on both geological disposal and the further optimization of surface disposal facilities, combining the goals of PREDIS (EU-project on Pre-disposal Management of Radioactive Waste) and EURAD-1 (on research topics related to geological disposal). EURAD-2 has a more strategic orientation, with 6 of the 18 work packages being strategic studies running for 2 years. The R&D studies will again run for 5 years. EURAD-2 is aiming to screen the status specific topics and the needs from different countries to either conclude elements of the research or prepare topics for more in-depth study. 🤝 Belgium, with more than 40 years of experience in deep geological disposal RD&D, remains a powerful voice at the European level. Belgian involvement can be found in 17 of the 18 work packages, which is truly impressive. We expect to learn a great deal from this project for our Belgian programme but also to contribute to the work thanks to our expertise and decades-long experience. #nuclearlifecycle #waste #disposal #research #Belgium

Reusing NORM waste to produce paper, cement and batteries - we are working on it! ☢️♻️ 🤝 Together with the FIC Fighters team, we aim to transform phosphogypsum waste into valuable materials for reuse in consumer products. SCK CEN will take on the radiological characterization of both the production site and the final recovered end-products. 🔬 Moreover, we will also assist with scientific studies and communication to inform the public about the benefits and safety of phosphogypsum recycling. 💬 Talk about multidisciplinarity and sustainability! 💪 Read more on our website: https://lnkd.in/evcv5Bnk #nuclearlifecycle #recycling #NORM #FICFighters #innovation #teamwork

Exciting results about terbium-161 and its potential in cancer treatment were shared by Kaat Spoormans during her presentation at #EANM 2024, recognized as one of the must-see sessions of the event! 💡 Terbium-161 has a unique property: when it decays, it emits both internal conversion and low-energy Auger electrons next to a beta particle. ☢️ Like alpha particles, these electrons travel very short distances, allowing a higher dose to accumulate locally near cancer cells with each injection. In theory, this results in a stronger therapeutic effect while sparing healthy tissue. 💬 "Our research shows that the internal conversion electrons emitted by Terbium-161 indeed deliver a significantly higher absorbed dose compared to Lutetium-177. However, to truly enhance the biological effectiveness of 161Tb, the Auger electrons must be precisely targeted at radiosensitive areas of the cell – such as the cell nucleus, the mitochondria or the cell membrane. While 161Tb-DOTATATE internalises into the cell cytoplasm, 161Tb-DOTA-LM3 binds to the cell membrane, allowing for a more focused and enhanced therapeutic effect," Kaat Spoormans explained. These insights are a significant step forward in precision cancer treatment. 🎯 Take away – European Association of Nuclear Medicine (EANM). Missed the session at EANM '24? You can find her paper here for all the details! 📄 https://lnkd.in/eCCHi-SC

📅 Only 1 day left to connect with us at the European Association of Nuclear Medicine (EANM) conference - don't miss out! Be sure to stop by and engage with our team. We're live at booth H32, where our experts are ready to share their insights on radioligand therapy. 💡 Swing by for practical tips and discover how our preclinical research can be your ideal partner in advancing cancer treatment. Learn more about our comprehensive services, from cutting-edge fundamental research to radiochemical purification. Together, let's achieve your strategic goals and make a significant impact on the future of healthcare! 💪 #EANM2024 #cancerresearch #healthcare #nuclearmedicine #Hamburg

How is SCK CEN a pioneer in radioligand therapies? 🔬 By leveraging our multidisciplinary expertise to fuel cancer research; 🔗 By enabling a supply chain for radioisotopes; 🏥 And by reaching out to clinical centers to treat patients. ☢️ Our vision is clear: collaborate to bring radioligand therapy to the next level and impact more lives around the globe. 🎥 Check out our video to learn how we are pushing the boundaries of cancer therapy. 👁️🗨️ Do you share this vision, this mission? Let's talk! https://lnkd.in/exqcYrmc

💉 Can Belgium become the hub for radioligand therapies against cancer? And what are we doing with SCK CEN to get our country into that pole position? Koen Hasaers, our Director of Nuclear Medical Applications, has an idea. 💡 Thanks to Novartis for the question and the video! What are your ambitions in the fight against cancer? 🎤 Tell us, for example during European Association of Nuclear Medicine (EANM). You will find us at booth H32!

Kudos to SpectronRx! 💪 Honored to host their first European readiolabeling facility at our site. Proud to collaborate and contribute to advancing nuclear medicine together!

📢 Dive into our detailed article on the site remedation project at the former Liepāja Metalurgs steel plant in Latvia: 🔗 https://lnkd.in/eEcqvgRN 🔬🤝 Our collaborative effort with Belgian experts IRE - Institute for radioelements, TRACTEBEL and Belgoprocess, supported by FOD Economie, is making significant strides in transforming this site into a green industrial zone. 🌳 #nuclearlifecycle #radioationprotection #siteremediation #safety #costefficiency #Belgium #Latvia

Will radioligand therapy become a new pillar in cancer care? Yes! 👌 ❌ But what are the main barriers? How to overcome those? Find out our answers in this Novartis' video. Let's join forces to help doctors to heal patients worldwide and give them a chance of a better future. Let's talk at European Association of Nuclear Medicine (EANM) later this week. We are at booth H32! Or book a meeting when it suits you. ➡️ https://lnkd.in/exqcYrmc

🎉 Our joint EU-SMR-LFR project received a vote of confidence from the European Industrial Alliance on Small Modular Reactors ☢️, an initiative by the European Commission, nucleareurope and SNETP. This will give a huge boost to the partners working on this; it only further strengthens our ambition to demonstrate the potential of lead-cooled, fast reactor technology." - 💬 Marc Schyns, director Innovative Nuclear Systems bij SCK CEN. ⚛️ Out of 21 project proposals, 9 were selected, underscoring Europe's confidence in SMRs as a key solution for the energy transition. 💪 Proud to collaborate with ENEA, Ansaldo Nuclear and RATEN on this ambitious journey! Full article: 🔗 https://lnkd.in/eZqe4kFc #SMR #nuclearinnovation #energy #ransition #sustainabilty #Europe